London
· Delayed Price · Currency is GBP · Price in EUR Euroapi Company Description
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use.
The company provides contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances, as well as lipids.
It offers their products to pharmaceutical, generic drug manufacturers, animal health product manufacturers, consumer health, nutrition and cosmetic product companies, biotech companies, and distribution companies, as well as contract development and manufacturing organization.
The company was incorporated in 2020 and is based in Paris, France.
| Country | France |
| Founded | 2020 |
| Industry | Medicinal Chemicals and Botanical Products |
| Employees | 3,187 |
| CEO | David Seignolle |
Contact Details
Address: 15 Rue Traversiere Paris, 75012 France | |
| Phone | 33 1 89 20 62 00 |
| Website | euroapi.com |
Stock Details
| Ticker Symbol | 0EAP |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| David Seignolle | Chief Executive Officer |
| Olivier Falut | Chief Financial Officer |
| Sophie Palliez | Head of Investor Relations |
| Marion Santin | Chief Legal, Compliance, and IP Officer |
| Ute Herzog | Chief Human Resources Officer |
| Vincent Touraille | Chief Strategy and M&A Officer |
| Frederic Lelievre | Chief Quality Officer |
| Emmanuel Mazeaud | Chief Digital Officer |
| Guillaume Rosso | Chief Commercial Officer |
| Laurence Bollack | Head of Global Media Relations |